10 research outputs found
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells
HIV-1 replicates in CD4+ T cells, leading to AIDS. Determining how HIV-1 shapes its niche to create a permissive environment is central to informing efforts to limit pathogenesis, disturb reservoirs, and achieve a cure. A key roadblock in understanding HIV-T cell interactions is the requirement to activate T cells in vitro to make them permissive to infection. This dramatically alters T cell biology and virus-host interactions. Here we show that HIV-1 cell-to-cell spread permits efficient, productive infection of resting memory T cells without prior activation. Strikingly, we find that HIV-1 infection primes resting T cells to gain characteristics of tissue-resident memory T cells (TRM), including upregulating key surface markers and the transcription factor Blimp-1 and inducing a transcriptional program overlapping the core TRM transcriptional signature. This reprogramming is driven by Vpr and requires Vpr packaging into virions and manipulation of STAT5. Thus, HIV-1 reprograms resting T cells, with implications for viral replication and persistence
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells.
open access articleHIV-1 replicates in CD4+ T cells, leading to AIDS. Determining how HIV-1 shapes its niche to create a permissive environment is central to informing efforts to limit pathogenesis, disturb reservoirs, and achieve a cure. A key roadblock in understanding HIV-T cell interactions is the requirement to activate T cells in vitro to make them permissive to infection. This dramatically alters T cell biology and virus-host interactions. Here we show that HIV-1 cell-to-cell spread permits efficient, productive infection of resting memory T cells without prior activation. Strikingly, we find that HIV-1 infection primes resting T cells to gain characteristics of tissue-resident memory T cells (TRM), including upregulating key surface markers and the transcription factor Blimp-1 and inducing a transcriptional program overlapping the core TRM transcriptional signature. This reprogramming is driven by Vpr and requires Vpr packaging into virions and manipulation of STAT5. Thus, HIV-1 reprograms resting T cells, with implications for viral replication and persistence
The role of Nef-mediated CD3 downmodulation during HIV-1 viral spread
HIV-1 most efficiently disseminates by direct cell-cell transmission that occurs at virological synapses (VS) formed between infected and uninfected CD4+ T cells. Previous work has shown that VS formation triggers antigen-independent T cell receptor (TCR) signalling in infected T cells to drive viral spread. Interestingly, the viral accessory protein Nef of HIV-2 and most SIV lineages, but not HIV-1, downmodulates CD3 - the signalling component of TCR complex. This impairs signalling at the immunological synapse and may interfere with antiviral responses and prevent aberrant immune activation. Why HIV-1 lost this potential immune evasion strategy remains incompletely understood. This question was addressed using chimeric HIV-1 viruses expressing SIVsmm Nef proteins and mutants thereof that differ specifically in their ability to downmodulate CD3. The results show that retained CD3 expression on infected cells resulted in enhanced viral cell-cell spread compared to viruses that downmodulate CD3 expression. Retained CD3 expression resulted in increased expression of functional envelope trimers (Env) on the surface of infected cells, increased Env incorporation into virions and thus increased virion infectivity, which was found to be the determinant for enhancement of viral spread. Increased Env expression and virion infectivity was shown to be dependent on VS formation and cell activation, thus explaining the role of CD3 and TCR signalling in this process. It was also observed that during cell cell spread the presence of CD3 on infected cells correlated with enhanced TCR signalling at the VS, increased cell activation, as well as increased cell death. In addition to SIVsmm, SIVmac and HIV-2 Nef chimeric viruses were also examined, as they originate from zoonotic transmissions from SIVsmm. Interestingly, SIVmac and HIV-2 Nef viruses did not show any differences in cell-cell spread, virion infectivity or cell activation that correlated with CD3 downmodulation as observed for SIVsmm Nef viruses. The reason for this remains unknown; however, it suggests that there may be additional species-specific Nef determinants that contribute to efficient viral spread. Taken together, the results suggest that HIV-1 might have lost Nef-mediated CD3 downmodulation activity to allow for more efficient viral replication while losing the ability to suppress T cell activation and cell death, which possibly contributes to increased viral pathogenicity of HIV-1
A Conserved Tryptophan in the Envelope Cytoplasmic Tail Regulates HIV-1 Assembly and Spread
The HIV-1 envelope (Env) is an essential determinant of viral infectivity, tropism and spread between T cells. Lentiviral Env contain an unusually long 150 amino acid cytoplasmic tail (EnvCT), but the function of the EnvCT and many conserved domains within it remain largely uncharacterised. Here, we identified a highly conserved tryptophan motif at position 757 (W757) in the LLP-2 alpha helix of the EnvCT as a key determinant for HIV-1 replication and spread between T cells. Alanine substitution at this position potently inhibited HIV-1 cell–cell spread (the dominant mode of HIV-1 dissemination) by preventing recruitment of Env and Gag to sites of cell–cell contact, inhibiting virological synapse (VS) formation and spreading infection. Single-molecule tracking and super-resolution imaging showed that mutation of W757 dysregulates Env diffusion in the plasma membrane and increases Env mobility. Further analysis of Env function revealed that W757 is also required for Env fusion and infectivity, which together with reduced VS formation, result in a potent defect in viral spread. Notably, W757 lies within a region of the EnvCT recently shown to act as a supporting baseplate for Env. Our data support a model in which W757 plays a key role in regulating Env biology, modulating its temporal and spatial recruitment to virus assembly sites and regulating the inherent fusogenicity of the Env ectodomain, thereby supporting efficient HIV-1 replication and spread
Loss of Nef-mediated CD3 down-regulation in the HIV-1 lineage increases viral infectivity and spread
SARS-CoV-2 evolution influences GBP and IFITM sensitivity.
SARS-CoV-2 spike requires proteolytic processing for viral entry. A polybasic furin-cleavage site (FCS) in spike, and evolution toward an optimized FCS by dominant variants of concern (VOCs), are linked to enhanced infectivity and transmission. Here we show interferon-inducible restriction factors Guanylate-binding proteins (GBP) 2 and 5 interfere with furin-mediated spike cleavage and inhibit the infectivity of early-lineage isolates Wuhan-Hu-1 and VIC. By contrast, VOCs Alpha and Delta escape restriction by GBP2/5 that we map to the spike substitution D614G present in these VOCs. Despite inhibition of spike cleavage, these viruses remained sensitive to plasma membrane IFITM1, but not endosomal IFITM2 and 3, consistent with a preference for TMPRSS2-dependent plasma membrane entry. Strikingly, we find that Omicron is unique among VOCs, being sensitive to restriction factors GBP2/5, and also IFITM1, 2, and 3. Using chimeric spike mutants, we map the Omicron phenotype and show that the S1 domain determines Omicron's sensitivity to GBP2/5, whereas the S2' domain determines its sensitivity to endosomal IFITM2/3 and preferential use of TMPRSS2-independent entry. We propose that evolution of SARS-CoV-2 for the D614G substitution has allowed for escape from GBP restriction factors, but the selective pressures on Omicron for spike changes that mediate antibody escape, and altered tropism, have come at the expense of increased sensitivity to innate immune restriction factors that target virus entry
SpyAvidin Hubs Enable Precise and Ultrastable Orthogonal Nanoassembly
The capture of biotin
by streptavidin is an inspiration for supramolecular
chemistry and a central tool for biological chemistry and nanotechnology,
because of the rapid and exceptionally stable interaction. However,
there is no robust orthogonal interaction to this hub, limiting the
size and complexity of molecular assemblies that can be created. Here
we combined traptavidin (a streptavidin variant maximizing biotin
binding strength) with an orthogonal irreversible interaction. SpyTag
is a peptide engineered to form a spontaneous isopeptide bond to its
protein partner SpyCatcher. SpyTag or SpyCatcher was successfully
fused to the C-terminus of Dead streptavidin subunits. We were able
to generate chimeric tetramers with <i>n</i> (0 ≤ <i>n</i> ≤ 4) biotin binding sites and 4-n SpyTag or SpyCatcher
binding sites. Chimeric SpyAvidin tetramers bound precise numbers
of ligands fused to biotin or SpyTag/SpyCatcher. Mixing chimeric tetramers
enabled assembly of SpyAvidin octamers (8 subunits) or eicosamers
(20 subunits). We validated assemblies using electrophoresis and native
mass spectrometry. Eicosameric SpyAvidin was used to cluster trimeric
major histocompatibility complex (MHC) class I:β<sub>2</sub>-microglobulin:peptide complexes, generating an assembly with up
to 56 components. MHC eicosamers surpassed the conventional MHC tetramers
in acting as a powerful stimulus to T cell signaling. Combining ultrastable
noncovalent with irreversible covalent interaction, SpyAvidins enable
a simple route to create robust nanoarchitectures
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
SARS-CoV-2 variants of concern (VOCs) emerged during the COVID-19 pandemic. Here, we used unbiased systems approaches to study the host-selective forces driving VOC evolution. We discovered that VOCs evolved convergent strategies to remodel the host by modulating viral RNA and protein levels, altering viral and host protein phosphorylation, and rewiring virus-host protein-protein interactions. Integrative computational analyses revealed that although Alpha, Beta, Gamma, and Delta ultimately converged to suppress interferon-stimulated genes (ISGs), Omicron BA.1 did not. ISG suppression correlated with the expression of viral innate immune antagonist proteins, including Orf6, N, and Orf9b, which we mapped to specific mutations. Later Omicron subvariants BA.4 and BA.5 more potently suppressed innate immunity than early subvariant BA.1, which correlated with Orf6 levels, although muted in BA.4 by a mutation that disrupts the Orf6-nuclear pore interaction. Our findings suggest that SARS-CoV-2 convergent evolution overcame human adaptive and innate immune barriers, laying the groundwork to tackle future pandemics